The owners of the German chemical company Evonik said on Friday that they had placed a combined stake of less than 10 percent with institutional investors as part of a renewed attempt at an initial public offering. Evonik, which is part owned by the private equity firm CVC Capital Partners, canceled plans to go public last year, and analysts say the new listing could value the company at more than $15 billion. Read more »
